ClinicalTrials.gg
RecruitingNCT06793865Updated Jan 27, 2025

Effect of Russian Current Stimulation for Anterior Tibial Group on Postural Stability and Risk of Falling in Patients With Stroke

An interventional study of Russian Current Stimulation for Anterior Tibial Group and Placebo Russian Current Stimulation for Anterior Tibial Group in Stroke, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 40 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-01-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Oct 2024, registered Jan 2025).
  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 41 studies in Stroke by Cairo University — 20 open to participants now, 22 under way, none of them phase 3. Stroke · Cairo University.

Planned enrollment
19th of 38
40 · median 40
Started
2024
with 7 others
No phase
38 of 41
19 open now
Primary completion
2025-02
later than 4 of 21 live
Registered
17th of 41
by date

Among the 41 studies in Stroke by Cairo University, this one is the 19th largest by planned enrollment of the 38 interventional ones that give a count, is one of 8 that started in 2024, is one of 38 with no phase, reaches primary completion later than 4 of the 21 other live ones, and was the 17th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

20 of the 41 studies in Stroke by Cairo University are open now, in 1 country. Recruiting first, the newest first:

14 more — sign in →

By country, each count listing its studies:

All 20 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 40 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 41 studies in Stroke by Cairo University, or all of them as a file.
02

Study summary

This study aimed to examine the effect of Russian current stimulation on Anterior tibial group on postural stability and risk of falling in patients with stroke.

Read the detailed description

Stroke is the second leading cause of death globally and the main cause of disability, with ischemic strokes accounting for about 87% of cases. In 2010, over 11 million ischemic strokes occurred, predominantly in low and middle-income countries, leading to approximately three million deaths. Hemorrhagic strokes account for 13% of cases.

Egypt, with an estimated population of 85.5 million, has a high stroke prevalence of 963 per 100,000 inhabitants. Postural imbalance is a common limitation, affecting 83% of acute stroke patients, and falls are frequent across all stages of recovery, with rates as high as 73% within six months post-discharge. Even in chronic stroke patients, the fall risk remains elevated compared to age-matched controls. Postural imbalance impacts quality of life, and rehabilitation is vital for regaining independence in daily activities.

Up to 30% of stroke survivors experience significant permanent disabilities, and 20% require rehabilitation. Motor impairments, particularly in the lower limbs, limit daily activities, community participation, and quality of life. Poor lower-limb muscle performance affects balance, gait, and functionality, but interventions like Russian current have shown effectiveness in improving walking performance and motor recovery in chronic stroke survivors.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
40 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Forty patient with stroke manifest with weakness of anterior tibial group.
  • Patients with moderate spasticity,
  • Patient's ages ranged from 40-55 years.
  • Patients not exceed 30 kg/m².
  • Medically and clinically stable patients.

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from psychological, cognitive, or emotional disturbance.
  • Patients with severe spasticity (3 or more by the modified Ashworth scale).
  • Patients with atrial fibrillation.
  • Patients with infectious processes.
  • Patients with impaired pain sensitivity.
  • Patients with epilepsy.
  • Patients with lower limb joint endoprosthetics.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Russian Current Stimulation + selected physical therapy exercise

    Patients received Russian current stimulation for 20 minutes and physical therapy for 40 minutes, 3 times/week for 6 weeks.

    Other: Russian Current Stimulation for Anterior Tibial Group · Other: Selected physical therapy exercise for both limbs

  • Placebo comparator
    Placebo Russian Current Stimulation + selected physical therapy exercise

    All patients in this group received Russian current for 20 minutes as placebo in addition to the same selected physical therapy exercise for both limbs for 40 minutes.

    Other: Placebo Russian Current Stimulation for Anterior Tibial Group · Other: Selected physical therapy exercise for both limbs

Interventions

  • OtherRussian Current Stimulation for Anterior Tibial Group

    Parameters were adjusted as the following frequency of 2.5 kHz and 50 bursts per second with 50 pulses per burst. The stimulus was applied for a 10 seconds "on" period followed by a 10 seconds "off" period for total treatment time 20 minutes.

  • OtherPlacebo Russian Current Stimulation for Anterior Tibial Group

    Placebo Russian current stimulation was applied to the anterior tibial group without active current for 20 minutes.

  • OtherSelected physical therapy exercise for both limbs

    The selected physical therapy exercise for both limbs was applied for 40 minutes, including passive, active assisted and active range of motion exercises, stretching of spastic muscles, strengthening of weak muscles (anterior tibial group), and finally functional mobility exercises.

06

What researchers measure

Primary outcomes

  1. Static postural stability overall stability index (OST)

    It was assessed for both groups through Biodex balance system. A training test was given to each patient followed by three consecutive tests in static mode. Each one lasted for 20 seconds with 10 seconds rest between each, changes were recorded in relation to the center of the platform, and the mean of three tests showing the postural fluctuations of women was automatically calculated by the device, and displayed on the screen of device.

    Time frame: 6 weeks

Secondary outcomes

  1. Berg balance scale

    It was used to assess the balance for all patients in both groups. The scale consists of 14 items, scored from 0 to 4, which are added to make a total score between 0 and 56. A higher score indicates better balance. The items vary in difficulty, from sitting in a chair to standing on one leg.

    Time frame: 6 weeks

  2. Risk of falls index

    Risk of falls index of all patients in both groups was assessed through Biodex balance system. All patients in both groups were asked to bilaterally stand on the locked platform; then were asked to look in front to the screen that will adjusted according to their height, the hands were placed comfortably beside the body and they were advised to use the handles of the device in case of loss of balance and repeat the test from the beginning.

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Feb 2025, 4 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 4 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Jan 27, 2025
StartActual
Oct 10, 2024
Primary completionEst.
Feb 10, 2025
CompletionEst.
Feb 10, 2025
Last update
Jan 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06793865
Lead sponsor
Cairo University
Responsible party
Abdelrahman Refaat Mohamed (Principal Investigator, Cairo University) — Principal investigator
First posted
Jan 27, 2025
Start date
Oct 10, 2024
Primary completion
Feb 10, 2025 (estimated)
Completion
Feb 10, 2025 (estimated)
Last update
Jan 27, 2025

Study contacts

Abdelrahman Refaat Mohamed, B.Sc
Contact
abdelrahmanrefaat56@gmail.com
01069278792
Hoda Mohamed Zakaria, PhD
Contact
Hoda Mohamed Zakaria, PhD
study chair · Professor, Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion